Thermo to Buy Biolab for $120M

Xconomy Boston — 

Thermo Fisher Scientific (NYSE:TMO), a Waltham, MA-based provider of scientific research products and services, says that it has struck a deal to buy Biolab, of Auckland, New Zealand, for about $120 million. The acquisition of Biolab—a supplier of analytical instruments, lab equipment, and research materials—expands Thermo’s market presence in New Zealand, Australia, and the South Pacific, according to Thermo. Biolab is the scientific and healthcare unit of multi-industry firm Alesco (ASX:ALS), headquartered in Sidney, Australia, and Thermo plans to integrate Biolab into its laboratory products and services division.